Search

AAD on BPO in Acne Products: “Research is Ongoing”

“Research on this issue is ongoing, and we continue to monitor new findings to ensure dermatologists and patients have the most accurate and up-to-date information. The U.S Food and Drug Administration (FDA) recently tested 95 benzoyl peroxide (BPO) acne products for benzene contamination, finding that over 90% had undetectable or extremely low levels, while a small number contained elevated levels, leading to voluntary recalls by a handful of companies. While some studies suggest potential connections between benzene and an elevated risk for certain diseases, like cancer, the potential risk is still being investigated.

If you have one of the recalled products listed on the FDA website, there is no immediate cause for concern. This is a retail-level recall, meaning stores and online retailers have been asked to stop selling these products. The FDA has not recommended that the public take any action at this time.

The Academy recommends that patients follow best practices for storing and handling products containing benzoyl peroxide and consult their dermatologist if they have any concerns. To minimize risk:

  • Store products according to the manufacturer’s instructions at room temperature or cooler conditions (e.g. refrigerated).
  • Replace products that contain benzoyl peroxide every 10-12 weeks.
  • Benzoyl peroxide products should be discarded if exposed to high temperatures (e.g. greater than 78°F).”

-Statement from American Academy of Dermatology President Susan C. Taylor, MD, FAAD